These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8287725)

  • 1. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X; Silva E; Gershenson D; Hung MC
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and expression of c-Ki-ras oncogene in human ovarian cancer.
    Chien CH; Chang KT; Chow SN
    Proc Natl Sci Counc Repub China B; 1990 Jan; 14(1):27-32. PubMed ID: 1696386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
    Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
    Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
    Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
    Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amplification of c-myc proto-oncogene in primary tumors, metastases and blood leukocytes of patients with ovarian cancer].
    Serova OM
    Eksp Onkol; 1987; 9(1):25-7. PubMed ID: 3028756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
    Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
    Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in copy number of c-erbB-2 and c-myc proto-oncogenes in advanced stage of human breast cancer.
    Tsuda H; Hirohashi S; Hirota T; Shimosato Y
    Acta Pathol Jpn; 1991 Jan; 41(1):19-23. PubMed ID: 1674395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
    Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
    Ueda M; Shimizu N; Abe O
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.
    Kacinski BM; Carter D; Kohorn EI; Mittal K; Bloodgood RS; Donahue J; Kramer CA; Fischer D; Edwards R; Chambers SK
    Yale J Biol Med; 1989; 62(4):379-92. PubMed ID: 2556864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.